Office of Digital Transformation’s 2022 Year In Review: The MAP To Success
Executive Summary
The FDA’s Office of Digital Transformation published its first full-year report summarizing its 2022 accomplishments and future strategic priorities.
You may also be interested in...
FDA Issues Framework For Use Of Digital Health Technologies In Drug Development
The FDA’s new framework for the use of digital health technologies will engage stakeholders to provide more guidelines for the industry.
FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics
The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal.
FDA Provides Update On Efforts To Modernize Its Technology And Data Collection
After launching its Data Modernization Action Plan (DMAP) one year ago, and its Technology Modernization Action Plan (TMAP) three years ago, the US Food and Drug Administration has provided an update to its progress with “Modernization in Action.”